InMed Pharmaceuticals (IN) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free IN Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInMed Pharmaceuticals (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studiestheglobeandmail.com - April 6 at 6:17 PMInMed Pharmaceuticals: InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Updatefinanznachrichten.de - February 13 at 6:22 PMInMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Updatefinance.yahoo.com - February 13 at 6:22 PMInMed Pharmaceuticals (NASDAQ: INM) CEO to Present at January Water Tower Research Fireside Chattheglobeandmail.com - January 22 at 12:09 PMInMed Pharmaceuticals Provides Business Update and Milestones for 2024finance.yahoo.com - January 16 at 12:11 PMInMed’s (NASDAQ: INM) Latest Research Demonstrates Potential In Treating Alzheimer’s with a Rare Cannabinoid Analogfinance.yahoo.com - December 12 at 12:03 PMInMed Pharmaceuticals (NASDAQ: INM) Advancing INM-089 to Target Treatment of Age-Related Macular Degenerationtheglobeandmail.com - November 30 at 1:40 PMInMed Expands its Pharmaceutical Pipeline with INM-089 targeting the treatment of Age-Related Macular Degenerationfinance.yahoo.com - November 29 at 9:11 AMInMed Pharmaceuticals GAAP EPS of -$0.76, revenue of $901.8Mmsn.com - November 14 at 10:10 AMInMed Pharmaceuticals Inc.'s INM-901 Demonstrates Unique Pharmacological Effects in Alzheimer's Disease in Preclinical Proof-of-Concept Studiesfinance.yahoo.com - October 24 at 7:55 AMCannabis Industry Report Highlights Positive Sentiment and Growth Potential at Benzinga Conferencebenzinga.com - October 13 at 1:50 PMDelveInsight Business Research, LLP: Epidermolysis Bullosa Market to Surge at a CAGR of ~8% During the Study Period (2019-2032), Predicts DelveInsightfinanznachrichten.de - August 11 at 6:18 PMInMed Provides Update on BayMedica Rare Cannabinoid Businessfinance.yahoo.com - July 20 at 9:57 AMGame-Changer In Epidermolysis Bullosa Treatment? Cannabis Compound Holds Promisemsn.com - July 7 at 3:36 PMBiosynthesis of Cannabinoids Market Growth By 2030marketwatch.com - April 25 at 1:36 PMBlepharitis-Pipeline Market Description and Business Overview By 2030marketwatch.com - April 20 at 10:35 AMInMed Pharmaceuticals: Pushing Pharma Forward With Rare Cannabinoidsbenzinga.com - March 27 at 3:08 PMDespite Global Economic Pressures, InMed Pharma's Accomplishments In 2022 Could Be A Catalyst For Further Growth In 2023benzinga.com - March 17 at 3:19 PMInMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditionsfinance.yahoo.com - March 13 at 9:58 AMInMed Pharmaceuticals Q2 FY23 Revenue Grows 77% YoY, What About Net Loss?benzinga.com - February 21 at 8:54 AMEpidermolysis Bullosa Market is Booming in Near Future 2023-2028 with Top Countries Datamarketwatch.com - February 20 at 8:17 AMInMed Pharmaceuticals Inc.: InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Updatefinanznachrichten.de - February 20 at 8:17 AMInMed Pharmaceuticals GAAP EPS of -$0.91, revenue of $0.47Mmsn.com - February 17 at 8:46 PMInMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Updateyahoo.com - February 17 at 8:46 PMInMed Submits Form 12b-25finance.yahoo.com - February 10 at 1:02 AMGlobal Blepharitis-Pipeline Market Size Growth Rate Analysis 2023 by Market Overview, Segments, Regions, Market Share and Forecast to 2028marketwatch.com - January 24 at 8:23 AMThinking about buying stock in Geron Corp, InMed Pharmaceuticals, Kingsoft Cloud, Vivos Therapeutics, or Baozun?marketwatch.com - January 4 at 10:04 AMSpasticity Treatment Market Research Highlighting Global Opportunities 2023 | Growth Trends and Share Forecast to 2029marketwatch.com - December 14 at 12:20 PMInMed Announces Appointment of Interim Chief Financial Officer and Change of Auditornz.finance.yahoo.com - December 12 at 6:59 PMBiotech Stock Roundup: CTMX Surges on REGN's Deal, APLS Up on Regulatory Updatemsn.com - November 23 at 2:01 PMInMed (INM) Gets Grant to Begin Neurodegenerative Diseases Programfinance.yahoo.com - November 17 at 12:23 PMWhy Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Sessionmsn.com - November 16 at 9:22 PMThinking about buying stock in Fast Radius, Camber Energy, InMed Pharmaceuticals, Taiwan Semiconductor, or Exela Technologies?benzinga.com - November 16 at 4:21 PMInMed stock rockets after research grant awarded for cannabinoid analogs to treat Alzheimer's, Parkinson'smsn.com - November 16 at 4:21 PMInMed Pharmaceuticals Inc.: InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Updatefinanznachrichten.de - November 12 at 7:27 AMInMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Updatebenzinga.com - November 12 at 1:12 AMInMed Pharmaceuticals Shares Rise 30% on Higher-Than-Normal Volumemarketwatch.com - September 30 at 1:06 PMInMed Pharma Gains 9%nasdaq.com - September 9 at 1:33 PMInMed Pharma to Consolidate Sharesmarketwatch.com - August 25 at 6:02 PMHere's Why InMed Pharmaceuticals Shares Are Getting Hammered Todayuk.investing.com - August 25 at 6:02 PMInMed Pharmaceuticals sinks 16% over consolidating 1 for 25 shares to meet listing requirementsseekingalpha.com - August 25 at 6:02 PMInMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosafinance.yahoo.com - July 25 at 8:19 AMInMed Pharma Names Michael Woudenberg As COOmarkets.businessinsider.com - July 18 at 9:58 AMInMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditionsfinance.yahoo.com - June 14 at 8:38 AMInMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sectorfinance.yahoo.com - June 9 at 7:57 AMEdison Investment Research Limited: InMed Pharmaceuticals : Notable Launches of High-Value Rare Cannabinoidsfinanznachrichten.de - May 4 at 8:26 PMThis is Why Investors Are Excited About the Potential of Rare Cannabinoidsbaystreet.ca - April 21 at 11:25 AMInMed Launching Additional Rare Cannabinoids In Response To Demandbenzinga.com - March 17 at 8:43 PMInMed CFO steps down, interim CFO appointedseekingalpha.com - March 17 at 3:43 PMInMed Pharma CFO Bruce Colwill To Retire - Quick Factsnasdaq.com - March 17 at 3:43 PM Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IN and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… IN Media Mentions By Week IN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IN News Sentiment▼0.000.44▲Average Medical News Sentiment IN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IN Articles This Week▼00▲IN Articles Average Week Get InMed Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LABS News Today CWEB News Today NDVA News Today WLLW News Today VPH News Today MPH News Today CTX News Today RX News Today VPT News Today IBT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:IN) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupWill this $2 AI stock double overnight?Behind the MarketsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
